RAMPART ic

?? We did it! ?? Rampart IC is honored to receive the Cardiovascular News Global Cardiovascular Award for Innovation in Patient and Operator Safety! This recognition reinforces our commitment to protecting interventional teams and advancing radiation safety through state-of-the-art shielding solutions. A huge thank you to the Global Cardiovascular Awards, our incredible team, and all the healthcare professionals who continue to trust Rampart to keep them protected. This is just the beginning. Let’s keep pushing the standard forward. ?? #DataMatters #YouAreWorthIt #ShedTheLead

?? #DataMatters | Real Data. Real Protection. Real Confidence. Radiation exposure for interventional teams is a lifelong risk, and your protection solution should be backed by robust clinical data. At Rampart IC, Data Matters. With two randomized controlled trials and a wealth of real-world evidence, we’ve built the strongest clinical foundation in radiation protection. ?? Kicking off our clinical data series: The Emory Randomized Controlled Trial: https://lnkd.in/gGpn3eMQ A head-to-head comparison of Rampart vs. traditional lead aprons and shields during cardiovascular procedures. The results? Rampart provides 20X more protection when compared to standard lead aprons and shields. ?? With Rampart, you don’t just get protection—you get confidence in your protection. It's time to #ShedTheLead and step into the future of radiation safety, backed by data that matters. Stay tuned as we break down the science, one publication at a time. #DataMatters #RadiationSafety #ShedTheLead #RampartIC #ClinicalEvidence

The Rampart portfolio of solutions is far more than just a single product.?With the addition of the Bunker, Sentry and Guardian products to our industry leading Defender platform, Rampart offers the most comprehensive suite of solutions in the market.?Our goal is to provide the same level of radiation and orthopedic protection TO EVERYONE in the room, regardless of position, and?WITHOUT?adding extra weight to your table!? ? While many use “phantom” data, Rampart’s clinical evidence leads the way, supported by two Randomized Controlled trials, multiple peer reviewed studies and a recently published 1,700?patient, real-world series! We provide clinically proven solutions so EVERYONE has the opportunity to #ShedTheLead!!

Radiation protection isn’t just about reducing exposure—it’s about protecting the long-term health and careers of interventionalists and their teams. A recent discussion during CRT highlighted the critical need for better shielding solutions that address both radiation exposure risks and the orthopedic strain caused by prolonged lead apron use. Two groundbreaking Rampart studies were presented: ?? The ERGO-CATH study, quantified the musculoskeletal strain physicians endure during interventional procedures, underscoring the need for less burdensome radiation protection solutions. ?? The newly published study, Real-World Reductions in Lead-Free Radiation Exposure with the Rampart System during Endovascular Procedures, demonstrating 99%+ head-to-toe radiation protection—allowing operators to work safely without the burden of lead aprons. At Rampart, we are proud to lead the way in clinically proven radiation protection. With two RCTs and multiple peer reviewed published studies, our solutions deliver unparalleled protection, ensuring that physicians and staff can focus on what matters most—patient care. Thank you to the leaders in this movement including Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM, Kenneth Rosenfield, and many more! #RadiationProtection #YouAreWorthIt #DataMatters #ShedTheLead

Welcome to the Team, Roy Peterka! Roy joins Rampart in the role of VP of Business Intelligence. With over 25 years of experience in medical devices, Roy has an extensive background in strategy, marketing, and sales force expansion. Most recently, Roy served as the Sr. Director of Strategy, Pricing and Contracting at Silk Road Medical. With the rapid adoption of Rampart’s industry leading solutions, Roy will play a critical role in our continued growth!

Rampart is heading to CRT 2025! Join us March 8-11 in Washington, DC for one of the leading educational forums in cardiovascular medicine. CRT - Cardiovascular Research Technologies is where the latest advancements in interventional cardiology, structural heart, endovascular, and beyond take center stage. At Rampart, we’re committed to redefining radiation protection. Our portfolio delivers head-to-toe shielding—without the burden of heavy lead aprons. Let’s talk about how we can provide TOTAL TEAM PROTECTION for you. ?? Stop by BOOTH #622 to learn more about our Rampart portfolio of solutions! #CRT2025 #ShedTheLead #RadiationSafety #CathLabProtection #InterventionalCardiology #YouAreWorthIt

?? The Data is Clear - Hazards of Radiation and Heavy Lead Aprons are Growing ?? The latest JSCAI survey on Occupational Health Hazards in the Cardiac Cath Lab confirms what many already feel—radiation exposure and orthopedic injuries are taking a serious toll on interventional teams. ?? 59.8% of respondents reported orthopedic injuries ?? 6.1% reported cancer diagnoses – a troubling increase from previous years ?? 71% of women surveyed wanted the option to step away from the CCL during pregnancy https://lnkd.in/e5sA3KSk At Rampart, we believe #YouAreWorthIt. That’s why our solutions provide industry-leading radiation protection while eliminating the need for heavy lead aprons—so you can protect your career, your health, and your future. ?? It’s time for a safer interventional suite. ?? It’s time to Shed the Lead. #ShedTheLead #RadiationSafety #YouAreWorthIt #InterventionalCardiology #CathLabSafety Society for Cardiovascular Angiography & Interventions

?? Live from CTO Plus! - 99.8% radiation attenuation across 7 cases at three sites. ?? Thank you to Cardiovascular Research Foundation for hosting another tremendous CTO Plus. We’re honored to support the majority of live cases featuring both the Guardian and Defender systems. From Columbia University Irving Medical Center to Henry Ford Health, Emory Healthcare, and beyond, interventionalists showcased advanced CTO techniques with the added benefit of shedding the lead with industry-leading radiation protection. It’s incredible to see these physicians pushing the boundaries of complex PCI to save patients lives while prioritizing safety for themselves and their teams. Thank you to the operators, staff, and institutions leading the way in radiation safety and procedural excellence! #CTOPlus #RadiationSafety #ShedTheLead #TotalTeamProtection

?? Rampart IC at SIF 2025! ?? We’re in Scottsdale for the Scottsdale Interventional Forum, where top experts tackle the latest in coronary, structural, and peripheral interventions. As interventional techniques evolve, so should radiation protection. Join us to see how Rampart is redefining safety in the cath lab. Visit the Rampart booth to learn how you can experience full-body protection and #ShedTheLead during your procedures. Follow us to learn more: https://lnkd.in/eKFfSRDc #SIF2025 #InterventionalCardiology #RadiationSafety #ShedTheLead #TotalTeamProtection

?? Radiation Safety Takes Center Stage at Pegasus Endovascular! ?? Join Dr. Bob Foster, founder of Rampart IC, at Pegasus Endovascular on Saturday, March 1st, as he presents: ?? "Radiation Reduction with the Rampart System" ?? Proven Protection Supported by Randomized Controlled Data. Lead Apron-Free Procedures. Rampart is transforming radiation safety for interventionalists, delivering 99%+ radiation attenuation while eliminating the orthopedic strain of heavy lead aprons. At Pegasus Endovascular, discover how Rampart’s shielding solutions are setting a new standard in radiation protection for the entire interventional team. ?? March 1st | Virtual Event: https://lnkd.in/eAmGhW9n ?? Be part of the future of safer procedures. #ShedTheLead #RadiationSafety #DataMatters #PegasusEndovascular